ArticleInternational journal of nephrology and renovascular disease2026
Validation and Evaluation of SPP1 as a Candidate Biomarker for Disease Monitoring in Focal Segmental Glomerulosclerosis.
Shanshan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.